• Epstein-Barr Vaccination Could Cut Risk of B-cell Lymphoma, Study Suggests
  • Getting Back Up Again
  • Velcade Add-on Doesn’t Improve Survival Outcomes in Newly Diagnosed DLBCL, Trial Shows
  • Japan Designates Valemetostat for Accelerated Development to Treat PTCL
  • Age, Obesity, Comorbidities Linked with Severe Fatigue Among Non-Hodgkin’s Lymphoma Survivors
  • Living In-between
  • Phase 1 Trial of CA-4948 Recruiting Non-Hodgkin’s Lymphoma Patients
  • First CTCL Patients Enrolled in Phase 2 Trial of Topical Treatment WP1220
  • Three-tiered Combination Stimulates Immune System to Attack Lymphoma Cells, Phase 1/2 Trial Shows
  • TG Therapeutics’ Umbralisib Proves Safe, Effective for Previously Treated Marginal Zone Lymphoma
  • Leukemia & Lymphoma Society’s Silicon Valley Chapter Raises $297K in ‘Student of the Year’ Contest
  • UK’s NICE Recommends Adcetris as Second-line Treatment for Certain CTCL Patients